Flow cytometric analysis of neoplastic nodules and hepatocellular carcinomas induced by ciprofibrate in the rat
1996

DNA Analysis of Liver Tumors in Rats

Sample size: 18 publication Evidence: moderate

Author Information

Author(s): CL Goolsby, MS Rao

Primary Institution: VA Lakeside Medical Center, Northwestern University Medical School

Hypothesis

Increases in the fraction of diploid cells is an important early event in the development of rat hepatocellular carcinoma (HCC).

Conclusion

The study found that ciprofibrate treatment leads to a significant increase in the fraction of diploid cells in both neoplastic nodules and HCC compared to surrounding non-tumorous tissue.

Supporting Evidence

  • Significant DNA tetraploid populations were seen in both neoplastic nodules and non-tumorous controls.
  • A significant increase in the percentage of DNA diploid cells was observed in the neoplastic nodule samples.
  • Seven of 27 HCC samples exhibited cell populations with DNA ploidy values distinct from those seen in non-tumorous controls.

Takeaway

The study looked at how certain changes in liver cells can lead to cancer in rats, showing that more diploid cells might be an early sign of cancer.

Methodology

Flow cytometric DNA content determinations were performed on liver samples from rats treated with ciprofibrate.

Limitations

The study primarily focused on DNA ploidy and did not explore other potential genetic changes.

Participant Demographics

Eighteen male Fisher 344 rats, approximately 8 weeks old.

Statistical Information

P-Value

0.003

Statistical Significance

p=0.003

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication